3 Results for "

intragastrically

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "intragastrically" in MCE Product Catalog:

6
6 Cited Publications
Cat. No.: HY-B0360
CAS No.: 90098-04-7
Synonyms: OPC12759; Proamipide
Target:  

COX

Research Areas:  

Inflammation/Immunology Cancer

Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer .
loading...
    loading...
Cat. No.: HY-Z0629
CAS No.: 90098-05-8
Target:  

Drug Intermediate

Research Areas:  

Others

Rebamipide impurity 1 is an impurity of Rebamipide (HY-B0360). Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury.
loading...
    loading...
Cat. No.: HY-B0360R
CAS No.: 90098-04-7
Target:  

COX Reference Standards

Research Areas:  

Inflammation/Immunology Cancer

Rebamipide (Standard) is the analytical standard of Rebamipide. This product is intended for research and analytical applications. Rebamipide (OPC12759) is an orally active gastroprotective agent that enhances the production of endogenous PGs (especially intragastric PGE2) by inducing COX-2 expression, thereby protecting the gastric mucosa from injury. Rebamipide exerts anti-proliferative activity against gastric cancer cells. Rebamipide can be used in studies of mucosal protection, gastroduodenal ulcer, gastritis and gastric cancer .
loading...
    loading...